uk central bank digital currency, Overview

The share price was 6 consecutive boards, and Shandong Fiberglass responded. On December 11th, the share price of Shandong Fiberglass went up again. Since December 4, the company's share price has been up and down for six consecutive trading days. In response to the abnormal fluctuation of the stock price, the reporter called Shandong Glass Fiber, and the company responded: "At present, the company's production and operation are all normal, and there is no significant information that should be disclosed but not disclosed. The short-term sharp fluctuation of stock price may be caused by overheated market sentiment. We remind investors that they should invest prudently and make rational decisions to avoid blindly chasing up. " (CSI Taurus)On the analysis of the daily limit at noon on December 11th, the three major indexes rose slightly, and consumer electronics concept stocks broke out collectively. Yiming food has 12 boards, Shandong glass fiber has 6 boards, one picture can be understood > >Before the Bank of Japan's policy meeting, it released chaotic signals. Japanese traders were confused about when to raise interest rates. After the Bank of Japan officials' remarks and media reports sent different signals, traders have been confused about when the central bank might raise interest rates in the past week. This kind of confusion led to sharp fluctuations in the market's interest rate hike bets. The overnight index swap pricing showed that the probability of raising interest rates in December was 22%, which was significantly lower than 60% at the beginning of last week. This week, the yen fell from 150 last Friday to a low of 152.18 to the dollar, and the exchange rate was 151.73 at 10:40 Tokyo time. Kazuo Ueda, governor of the Bank of Japan, said in an interview last month that the interest rate hike was approaching. A few days later, a report by the news agency emphasized the concern of the central bank about raising interest rates prematurely. Tomaki Nakamura, a member of the Dove Policy Committee, said last week that he was not opposed to raising interest rates, but this month's policy decision must consider data factors.

Can TCL make a three-fold mobile phone? Li Dongsheng responded: We have the technology, depending on the needs of the market. At the TCL Global Technology Innovation Conference held today, Li Dongsheng, the founder and chairman of TCL, attended the conference for the 11th time and made a live speech. At this conference, TCL exhibited and introduced the first Tandem three-fold screen (7.85 ") developed by the company. The folding screen can support "G-shaped" or "Z-shaped" folding, and combines Tandem, LTPO and PLP multiple low-power technologies to realize comprehensive promotion of high brightness, low power consumption and long service life. Will TCL launch three-fold mobile phones and other products? In the communication with Sina Technology, Li Dongsheng responded that "we have such technology", but we need to "see the market needs" whether to launch related products. (Sina Technology)Yushi Technology: There is no factual basis for the company to be included in the "entity list". At present, the production and operation are normal. Yushi Technology issued a statement today: On December 10, 2024 (Beijing time), the Bureau of Industry and Security of the US Department of Commerce issued relevant announcements to include companies such as Yushi Technology in the entity list. There is no factual basis for this decision, and the company has never received any investigation and evidence collection work from any official US agency. We call on the US government to re-examine. Yushi Technology is an independent private enterprise. As a global provider of AloT products, solutions and full-stack capabilities, Yushi Technology has always adhered to the internationally accepted business ethics and compliance management concept since its establishment 13 years ago, abided by the duties of commercial companies and strictly abided by the laws and regulations of the countries where it operates. At present, the company's production and operation are normal, and this incident has no significant adverse impact on the company's operation. We have the ability to ensure continuous and stable product supply and high-quality technical support for global customers.South Korea's former defense minister tried to commit suicide in prison. The Korean Ministry of Justice disclosed details. According to Yonhap News Agency's report on the 11th, South Korea's former defense minister Jin Longxian attempted suicide in prison on the evening of 10th. In response, Shen Ronghai, head of the Department of Corrections of the Korean Ministry of Justice, said that at present, Jin Longxian "has no abnormal physical condition." According to the report, Shen Ronghai said on the 11th that at around 11: 52 last night (10th), before the arrest warrant was issued, the staff found him trying to connect clothes into a rope in the bathroom in an attempt to commit suicide. Shen Ronghai added that the staff immediately took action and opened the door, and then Jin Longxian gave up suicide. At present, Jin Longxian has been placed in the protection room, and according to the report, his physical condition is not abnormal for the time being. (Yonhap News Agency)

Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).